Similar articles

• The impact of positron emission tomography on clinical decision making in a university-based multidisciplinary lung cancer practice.

  Sachs S, Bilfinger TV. Sachs S, et al. Chest. 2005 Aug;128(2):698-703. doi: 10.1378/chest.128.2.698. Chest. 2005. PMID: 16100156
• Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.

  Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D. Lee BE, et al. J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. doi: 10.1016/j.jtcvs.2007.09.029. Epub 2008 Jan 11. J Thorac Cardiovasc Surg. 2008. PMID: 18329480
• [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].

  Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH. Xu HF, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):108-11. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854393 Chinese.
• Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer.

  Detterbeck FC, Vansteenkiste JF, Morris DE, Dooms CA, Khandani AH, Socinski MA. Detterbeck FC, et al. Chest. 2004 Nov;126(5):1656-66. doi: 10.1378/chest.126.5.1656. Chest. 2004. PMID: 15539740 Review.
• [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].

  Vaylet F, Bonnichon A, Salles Y, Gontier E, Bonardel G, Lefloch H, Mairovitz A, Mantzarides M, Niang A, Marotel C, Foehrenbach H. Vaylet F, et al. Cancer Radiother. 2007 Jan-Feb;11(1-2):16-22. doi: 10.1016/j.canrad.2006.10.003. Epub 2006 Nov 29. Cancer Radiother. 2007. PMID: 17137819 Review. French.